5M PRODUCT
naptil-plus Naphazoline HCL, Chlorpheniramine Maleate & Methylcellulose Eye-Ear Drops
Ophthalmic PHARMACEUTICAL PRODUCT

naptil-plus Naphazoline HCL, Chlorpheniramine Maleate & Methylcellulose Eye-Ear Drops

Strength 5M HIST
Packing 5 ML
Published by 5M Biotech India
Last updated 3 November 2026
Company Profile →
PRODUCT INFORMATION

About naptil-plus Naphazoline HCL, Chlorpheniramine Maleate & Methylcellulose Eye-Ear Drops

Product information published by 5M Biotech India.

Active Ingredient Naphazoline HCL, Chlorpheniramine Maleate & Methylcellulose
Brand Naptil-Plus
Country of origin India
Form Ophthalmic Solution

Naptil-Plus Eye-Ear Drops is a combination formulation containing Naphazoline Hydrochloride, Chlorpheniramine Maleate, and Methylcellulose. It provides soothing and supportive care for eye and ear discomfort.

Clinical Uses

Naptil-Plus Eye-Ear Drops is used for managing-

  • Relief from eye redness and irritation.
  • Management of allergic eye symptoms such as itching and watering.
  • Temporary relief from minor eye discomfort.
  • Relief of allergic or inflammatory ear symptoms.

How It Works

Naptil-Plus Eye-Ear Drops work through the combined action of three ingredients. Naphazoline Hydrochloride helps reduce redness, Chlorpheniramine Maleate helps control allergic symptoms, and Methylcellulose provides a soothing and lubricating effect.

Side Effects

Some of the common side effects of using Naptil-Plus Eye-Ear Drops include-

  • Temporary burning.
  • Mild eye irritation.
  • Blurred vision.
  • Temporary redness of the eyes.

Precautions & Warnings

  • Avoid touching the dropper tip to any surface to prevent contamination.
  • Do not use the product if the solution appears discoloured.
  • Consult a doctor before use if you have any pre-existing eye or ear conditions.
  • Use with caution during pregnancy and breastfeeding.
  • Avoid driving or operating machinery if temporary blurred vision occurs.

Drug Interactions

A few medicines that you should not take while using Naptil Plus Eye-Ear drops include-

  • MAO Inhibitors: May increase the risk of cardiovascular effects associated with Naphazoline.
  • Tricyclic Antidepressants: May enhance the effects of Naphazoline and increase the risk of blood pressure changes.
  • Other Antihistamines: Concurrent use may increase antihistamine-related side effects.
  • Other Eye or Ear drops: Using multiple topical products together may cause irritation or affect treatment outcomes.

This is not all the possible drug interactions of Naptil Plus Eye-Ear drops. Consult a doctor before taking any medicine.

Disclaimer

At 5M Biotech India we provide accurate, reliable and expert reviewed information. However, all our content on this platform is intended for informational purposes only and is not professional medical advice, diagnosis or treatment. While we make efforts to maintain accuracy, the information may contain mistakes, omissions or may not reflect the latest developments. Always consult your doctor regarding any medical concerns.

All medicine names, trademarks, and registered trademarks displayed on 5M Biotech India are property of their respective owners. 5M Biotech India and its operator are not affiliated with, endorsed by or authorized by any such trademark owners unless stated expressly. Any reference to trademarks or product names is made for informational purposes. No sponsorship, commercial relationship, approval or association with any trademark owner should be inferred. Information provided herein does not constitute advertising, promotion or an offer for sale of any medicinal goods and is intended solely for general informational purposes.

All trademarks, trade names, and brand names displayed on this website are used strictly in accordance with the applicable provisions of the Trade Marks Act, 1999, including Sections 30 and 30(1) relating to permitted and fair use. The respective trademark ownership has been duly and accurately identified under the “Manufacturer/TM Owner” section in compliance with applicable statutory requirements.

Publisher 5M Biotech India
Last Updated 3 November 2026
Product Record #743
Therapeutic Area Ophthalmic
PRODUCT ENQUIRY

Discuss naptil-plus Naphazoline HCL, Chlorpheniramine Maleate & Methylcellulose Eye-Ear Drops